#test #vaccine #skin #cancer
“This is one of the most exciting things we’ve seen in a long time,” said Dr. Heather Shaw, researcher and national coordinator of the trial.
The University College London Hospitals NHS Foundation Trust is carrying out a final phase 3 trial of the first personalized messenger RNA vaccine against skin cancer in the United Kingdom, local media reported this Friday.
Doctors have begun testing hundreds of patients with new, custom-designed injections that tell their bodies to look for cancer cells to prevent the disease from coming back.
“This is one of the most exciting things we’ve seen in a long time,” said Dr. Heather Shaw, researcher and national coordinator of the trial.
“This is a really perfected tool […] “Patients are really excited about it,” he added.
In this sense, he pointed out that mRNA-4157 (V940) has the potential to cure people who have melanoma, but that it is also being tested in other types of cancer, including lung, bladder and kidney cancer.
Have the information instantly on your cell phone. Join the Diario Primicia group on WhatsApp through the following link: https://chat.whatsapp.com/EYG9YmFLInNEV9d04FckjG
We are also on Telegram as @DiarioPrimicia, join here: https://t.me/diarioprimicia
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/PK4LAZDB5ZAFLMJV76MQYLBG4M.png)
:format(url)/cloudfront-us-east-1.images.arcpublishing.com/lescoopsdelinformation/2CTLDE26X5BZDPSFELGKBBBFWU.jpeg)
